Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Pirisi

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Toxicologic Pathology|January 1, 1987
The variations of S-adenosyl-L-methionine content modulate hepatocyte growth during phenobarbital promotion of diethylnitrosamine-induced rat liver carcinogenesisF Feo, R Garcea, R Pascale, et al.
Oncogene|August 2, 2000
Unique carboxyl-terminal sequences of wild type and alternatively spliced variant forms of transforming growth factor-alpha precursors mediate specific interactions with ErbB4 and ErbB2X Xu, K F Kelleher, J Liao, et al.
European Journal of Cancer & Clinical Oncology|March 1, 1983
The subcellular distribution and properties of aldehyde dehydrogenase of hepatoma AH-130R A Canuto, R Garcea, M Biocca, et al.
Cancer Research|January 1, 1992
Increased sensitivity of human keratinocytes immortalized by human papillomavirus type 16 DNA to growth control by retinoidsL Pirisi, A Batova, G R Jenkins, et al.
Journal of Women'S Health & Gender-Based Medicine|July 11, 2001
Hormonal and barrier methods of contraception, oncogenic human papillomaviruses, and cervical squamous intraepithelial lesion developmentA L Coker, L C Sanders, S M Bond, et al.
Virology|May 4, 2000
Loss of transforming growth factor-beta (TGF-beta) receptor type I mediates TGF-beta resistance in human papillomavirus type 16-transformed human keratinocytes at late stages of in vitro progressionY Mi, D R Borger, P R Fernandes, et al.
Experimental and Molecular Pathology|March 27, 2001
High-risk HPVs and risk of cervical neoplasia: a nested case-control studyA L Coker, T Gerasimova, M R King, et al.
Pediatric Pharmacology (New York, N.Y.)|January 1, 1983
Effect of phenobarbital treatment on erythrocyte glucose-6-phosphate dehydrogenase in human newbornsE Laconi, S Dessì, B Batetta, et al.
Toxicologic Pathology|January 1, 1984
Modulatory mechanisms of chemical carcinogenesis: the role of the NADPH pool in the benzo(a)pyrene activationF Feo, L Pirisi, R Pascale, et al.
Experimental Cell Research|November 5, 1997
Glucocorticoids stimulate growth of human papillomavirus type 16 (HPV16)-immortalized human keratinocytes and support HPV16-mediated immortalization without affecting the levels of HPV16 E6/E7 mRNAM A Khan, A J Canhoto, P R Housley, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Toxicologic Pathology|January 1, 1987
The variations of S-adenosyl-L-methionine content modulate hepatocyte growth during phenobarbital promotion of diethylnitrosamine-induced rat liver carcinogenesisF Feo, R Garcea, R Pascale, et al.
Oncogene|August 2, 2000
Unique carboxyl-terminal sequences of wild type and alternatively spliced variant forms of transforming growth factor-alpha precursors mediate specific interactions with ErbB4 and ErbB2X Xu, K F Kelleher, J Liao, et al.
European Journal of Cancer & Clinical Oncology|March 1, 1983
The subcellular distribution and properties of aldehyde dehydrogenase of hepatoma AH-130R A Canuto, R Garcea, M Biocca, et al.
Cancer Research|January 1, 1992
Increased sensitivity of human keratinocytes immortalized by human papillomavirus type 16 DNA to growth control by retinoidsL Pirisi, A Batova, G R Jenkins, et al.
Journal of Women'S Health & Gender-Based Medicine|July 11, 2001
Hormonal and barrier methods of contraception, oncogenic human papillomaviruses, and cervical squamous intraepithelial lesion developmentA L Coker, L C Sanders, S M Bond, et al.
Virology|May 4, 2000
Loss of transforming growth factor-beta (TGF-beta) receptor type I mediates TGF-beta resistance in human papillomavirus type 16-transformed human keratinocytes at late stages of in vitro progressionY Mi, D R Borger, P R Fernandes, et al.
Experimental and Molecular Pathology|March 27, 2001
High-risk HPVs and risk of cervical neoplasia: a nested case-control studyA L Coker, T Gerasimova, M R King, et al.
Pediatric Pharmacology (New York, N.Y.)|January 1, 1983
Effect of phenobarbital treatment on erythrocyte glucose-6-phosphate dehydrogenase in human newbornsE Laconi, S Dessì, B Batetta, et al.
Toxicologic Pathology|January 1, 1984
Modulatory mechanisms of chemical carcinogenesis: the role of the NADPH pool in the benzo(a)pyrene activationF Feo, L Pirisi, R Pascale, et al.
Experimental Cell Research|November 5, 1997
Glucocorticoids stimulate growth of human papillomavirus type 16 (HPV16)-immortalized human keratinocytes and support HPV16-mediated immortalization without affecting the levels of HPV16 E6/E7 mRNAM A Khan, A J Canhoto, P R Housley, et al.
Pageof 4